Olanzapine/Samidorphan: A New Option for the Treatment of Adults With Schizophrenia or Bipolar I Disorder.

Huy M Pham Halford Warlick Ricardo BermudezQuan NguyenJose A Rey

Published in: The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians (2022)

The new combination treatment of OLZ/SAM is a unique antipsychotic formulation to provide the recognized efficacious treatment of OLZ, while mitigating the weight gain and possibly the weight-related adverse effects secondary to OLZ monotherapy.

Keyphrases

weight gain
body mass index
bipolar disorder
combination therapy
physical activity
randomized controlled trial
weight loss
drug delivery
open label
replacement therapy
study protocol
smoking cessation